trending Market Intelligence /marketintelligence/en/news-insights/trending/fyfjq3unaf7yw6dybdfdqw2 content esgSubNav
In This List

Wize Pharma shareholders approve reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Wize Pharma shareholders approve reverse stock split

Israel's Wize Pharma Inc. said its shareholders approved a reverse stock split at a Feb. 19 special meeting.

Under the company's amended certificate of incorporation, the board can effect a reverse stock split by a ratio between 1-for-10 and 1-for-200 at any time before Feb. 19, 2019.